FDA
Division Director-OPQ/OPMA/DPMAII
Dr. Arigo is the Director of the Division of Pharmaceutical Manufacturing Assessment 2 in the Office of Pharmaceutical Manufacturing Assessment at the FDA. His division focuses on the sterility assurance and manufacturing review to support ANDA, NDA, and IND submissions. He began his career with the Office of Generic Drugs Microbiology team in 2008 and has been involved in multiple reorganizations to the current state. Dr. Arigo obtained his Ph.D. from The Johns Hopkins University School of Medicine.